NO313140B1 - Fremgangsmåte ved fremstilling av makrosykliske chelatdannere og chelater derav med paramagnetiske metallioner - Google Patents
Fremgangsmåte ved fremstilling av makrosykliske chelatdannere og chelater derav med paramagnetiske metallioner Download PDFInfo
- Publication number
- NO313140B1 NO313140B1 NO19996077A NO996077A NO313140B1 NO 313140 B1 NO313140 B1 NO 313140B1 NO 19996077 A NO19996077 A NO 19996077A NO 996077 A NO996077 A NO 996077A NO 313140 B1 NO313140 B1 NO 313140B1
- Authority
- NO
- Norway
- Prior art keywords
- formula
- compound
- reaction
- xii
- acid
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 44
- 230000005298 paramagnetic effect Effects 0.000 title claims abstract description 14
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- 239000002738 chelating agent Substances 0.000 title claims 2
- 229910021645 metal ion Inorganic materials 0.000 title description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 22
- 150000003839 salts Chemical class 0.000 claims abstract description 20
- 239000007864 aqueous solution Substances 0.000 claims abstract description 17
- 238000006243 chemical reaction Methods 0.000 claims abstract description 16
- 150000002500 ions Chemical class 0.000 claims abstract description 10
- 229910052751 metal Inorganic materials 0.000 claims abstract description 9
- 239000002184 metal Substances 0.000 claims abstract description 9
- 238000011026 diafiltration Methods 0.000 claims abstract description 8
- 238000006460 hydrolysis reaction Methods 0.000 claims abstract description 8
- GKASDNZWUGIAMG-UHFFFAOYSA-N triethyl orthoformate Chemical compound CCOC(OCC)OCC GKASDNZWUGIAMG-UHFFFAOYSA-N 0.000 claims abstract description 8
- 238000005804 alkylation reaction Methods 0.000 claims abstract description 7
- QBPPRVHXOZRESW-UHFFFAOYSA-N 1,4,7,10-tetraazacyclododecane Chemical compound C1CNCCNCCNCCN1 QBPPRVHXOZRESW-UHFFFAOYSA-N 0.000 claims abstract description 5
- 238000011033 desalting Methods 0.000 claims abstract description 5
- GUVXZFRDPCKWEM-UHFFFAOYSA-N pentalene Chemical compound C1=CC2=CC=CC2=C1 GUVXZFRDPCKWEM-UHFFFAOYSA-N 0.000 claims abstract description 5
- 230000029936 alkylation Effects 0.000 claims abstract description 4
- 238000002425 crystallisation Methods 0.000 claims abstract description 4
- 230000008025 crystallization Effects 0.000 claims abstract description 4
- 239000003456 ion exchange resin Substances 0.000 claims abstract description 4
- 229920003303 ion-exchange polymer Polymers 0.000 claims abstract description 4
- 238000011084 recovery Methods 0.000 claims abstract description 4
- 238000010668 complexation reaction Methods 0.000 claims abstract description 3
- 150000001875 compounds Chemical class 0.000 claims description 35
- 239000011347 resin Substances 0.000 claims description 14
- 229920005989 resin Polymers 0.000 claims description 14
- 239000012535 impurity Substances 0.000 claims description 11
- 229910052688 Gadolinium Inorganic materials 0.000 claims description 10
- 239000002253 acid Substances 0.000 claims description 10
- 230000002378 acidificating effect Effects 0.000 claims description 10
- 150000001768 cations Chemical class 0.000 claims description 8
- FGUUSXIOTUKUDN-IBGZPJMESA-N C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 Chemical compound C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 FGUUSXIOTUKUDN-IBGZPJMESA-N 0.000 claims description 7
- 150000002924 oxiranes Chemical class 0.000 claims description 7
- 150000001450 anions Chemical class 0.000 claims description 6
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 claims description 5
- 238000011097 chromatography purification Methods 0.000 claims description 4
- WBJINCZRORDGAQ-UHFFFAOYSA-N ethyl formate Chemical compound CCOC=O WBJINCZRORDGAQ-UHFFFAOYSA-N 0.000 claims description 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 4
- 239000002245 particle Substances 0.000 claims description 4
- 239000003377 acid catalyst Substances 0.000 claims description 3
- 125000003545 alkoxy group Chemical group 0.000 claims description 3
- 125000000217 alkyl group Chemical group 0.000 claims description 3
- 239000002585 base Substances 0.000 claims description 3
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims description 3
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical group OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 claims description 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 3
- 239000011159 matrix material Substances 0.000 claims description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 3
- -1 phenyloxy, phenyldioxy group Chemical group 0.000 claims description 3
- 239000002904 solvent Substances 0.000 claims description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 2
- 229910052692 Dysprosium Inorganic materials 0.000 claims description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 2
- 229910052769 Ytterbium Inorganic materials 0.000 claims description 2
- 239000003513 alkali Substances 0.000 claims description 2
- 229910052791 calcium Inorganic materials 0.000 claims description 2
- 239000011575 calcium Substances 0.000 claims description 2
- 125000004432 carbon atom Chemical group C* 0.000 claims description 2
- 150000001732 carboxylic acid derivatives Chemical group 0.000 claims description 2
- 239000003054 catalyst Substances 0.000 claims description 2
- 150000002739 metals Chemical class 0.000 claims description 2
- 229910052700 potassium Inorganic materials 0.000 claims description 2
- 239000011591 potassium Substances 0.000 claims description 2
- 230000035484 reaction time Effects 0.000 claims description 2
- 229910052708 sodium Inorganic materials 0.000 claims description 2
- 239000011734 sodium Substances 0.000 claims description 2
- 229910052739 hydrogen Inorganic materials 0.000 claims 2
- 239000001257 hydrogen Substances 0.000 claims 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 claims 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 claims 1
- 238000000746 purification Methods 0.000 abstract description 4
- 150000002118 epoxides Chemical class 0.000 abstract 1
- 239000000047 product Substances 0.000 description 22
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 21
- DPNNNPAKRZOSMO-UHFFFAOYSA-K gadoteridol Chemical compound [Gd+3].CC(O)CN1CCN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC1 DPNNNPAKRZOSMO-UHFFFAOYSA-K 0.000 description 14
- 229960005451 gadoteridol Drugs 0.000 description 14
- 239000000243 solution Substances 0.000 description 14
- ZPDFIIGFYAHNSK-CTHHTMFSSA-K 2-[4,10-bis(carboxylatomethyl)-7-[(2r,3s)-1,3,4-trihydroxybutan-2-yl]-1,4,7,10-tetrazacyclododec-1-yl]acetate;gadolinium(3+) Chemical compound [Gd+3].OC[C@@H](O)[C@@H](CO)N1CCN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC1 ZPDFIIGFYAHNSK-CTHHTMFSSA-K 0.000 description 11
- 229960003411 gadobutrol Drugs 0.000 description 11
- 230000015572 biosynthetic process Effects 0.000 description 9
- UIWYJDYFSGRHKR-UHFFFAOYSA-N gadolinium atom Chemical compound [Gd] UIWYJDYFSGRHKR-UHFFFAOYSA-N 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 238000001728 nano-filtration Methods 0.000 description 5
- 125000004433 nitrogen atom Chemical group N* 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 239000012045 crude solution Substances 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- 239000000543 intermediate Substances 0.000 description 4
- 238000005342 ion exchange Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 4
- GEKNCWQQNMEIMS-UHFFFAOYSA-N 4,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]octane Chemical compound C1OC(C)(C)OCC2OC21 GEKNCWQQNMEIMS-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- IQUHNCOJRJBMSU-UHFFFAOYSA-N H3HP-DO3A Chemical compound CC(O)CN1CCN(CC(O)=O)CCN(CC(O)=O)CCN(CC(O)=O)CC1 IQUHNCOJRJBMSU-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- ZSXGLVDWWRXATF-UHFFFAOYSA-N N,N-dimethylformamide dimethyl acetal Chemical compound COC(OC)N(C)C ZSXGLVDWWRXATF-UHFFFAOYSA-N 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 239000006227 byproduct Substances 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 238000010511 deprotection reaction Methods 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- BNWCETAHAJSBFG-UHFFFAOYSA-N tert-butyl 2-bromoacetate Chemical compound CC(C)(C)OC(=O)CBr BNWCETAHAJSBFG-UHFFFAOYSA-N 0.000 description 3
- 125000003837 (C1-C20) alkyl group Chemical group 0.000 description 2
- PTZQGISORONQSJ-UHFFFAOYSA-N 2-[4,10-bis(carboxymethyl)-7-formyl-1,4,7,10-tetrazacyclododec-1-yl]acetic acid Chemical compound OC(=O)CN1CCN(CC(O)=O)CCN(C=O)CCN(CC(O)=O)CC1 PTZQGISORONQSJ-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 102100024167 C-C chemokine receptor type 3 Human genes 0.000 description 2
- 101710149862 C-C chemokine receptor type 3 Proteins 0.000 description 2
- 229910003317 GdCl3 Inorganic materials 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 2
- 239000002250 absorbent Substances 0.000 description 2
- 230000002745 absorbent Effects 0.000 description 2
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 2
- FOCAUTSVDIKZOP-UHFFFAOYSA-N chloroacetic acid Chemical compound OC(=O)CCl FOCAUTSVDIKZOP-UHFFFAOYSA-N 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 238000010612 desalination reaction Methods 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 238000010494 dissociation reaction Methods 0.000 description 2
- 230000005593 dissociations Effects 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 229940075613 gadolinium oxide Drugs 0.000 description 2
- 229910001938 gadolinium oxide Inorganic materials 0.000 description 2
- MEANOSLIBWSCIT-UHFFFAOYSA-K gadolinium trichloride Chemical compound Cl[Gd](Cl)Cl MEANOSLIBWSCIT-UHFFFAOYSA-K 0.000 description 2
- CMIHHWBVHJVIGI-UHFFFAOYSA-N gadolinium(iii) oxide Chemical compound [O-2].[O-2].[O-2].[Gd+3].[Gd+3] CMIHHWBVHJVIGI-UHFFFAOYSA-N 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 239000003446 ligand Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000002595 magnetic resonance imaging Methods 0.000 description 2
- 125000004430 oxygen atom Chemical group O* 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 238000004064 recycling Methods 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- LXILGZQWYDINMA-UHFFFAOYSA-N 1,4,7,10-tetrazacyclododecane-1-carbaldehyde Chemical compound O=CN1CCNCCNCCNCC1 LXILGZQWYDINMA-UHFFFAOYSA-N 0.000 description 1
- HHLZCENAOIROSL-UHFFFAOYSA-N 2-[4,7-bis(carboxymethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetic acid Chemical class OC(=O)CN1CCNCCN(CC(O)=O)CCN(CC(O)=O)CC1 HHLZCENAOIROSL-UHFFFAOYSA-N 0.000 description 1
- DPNNNPAKRZOSMO-UHFFFAOYSA-N 2-[4,7-bis(carboxymethyl)-10-(2-hydroxypropyl)-1,4,7,10-tetrazacyclododec-1-yl]acetic acid;gadolinium(3+) Chemical compound [Gd+3].CC(O)CN1CCN(CC(O)=O)CCN(CC(O)=O)CCN(CC(O)=O)CC1 DPNNNPAKRZOSMO-UHFFFAOYSA-N 0.000 description 1
- 230000005526 G1 to G0 transition Effects 0.000 description 1
- 150000000921 Gadolinium Chemical class 0.000 description 1
- 101100340769 Homo sapiens ILF2 gene Proteins 0.000 description 1
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 1
- 102000049951 Nuclear Factor 45 Human genes 0.000 description 1
- 108700031302 Nuclear Factor 45 Proteins 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 1
- 125000002777 acetyl group Chemical class [H]C([H])([H])C(*)=O 0.000 description 1
- 239000003929 acidic solution Substances 0.000 description 1
- 229910001860 alkaline earth metal hydroxide Inorganic materials 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 239000012455 biphasic mixture Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 229920001429 chelating resin Polymers 0.000 description 1
- 239000007806 chemical reaction intermediate Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940106681 chloroacetic acid Drugs 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000002872 contrast media Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000012631 diagnostic technique Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 239000000383 hazardous chemical Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 231100001231 less toxic Toxicity 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 230000005291 magnetic effect Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 125000005546 pivalic acid group Chemical group 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000013341 scale-up Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- PIOSEDPFJPAJKQ-UHFFFAOYSA-M sodium;toluene;hydroxide Chemical compound [OH-].[Na+].CC1=CC=CC=C1 PIOSEDPFJPAJKQ-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- VIOLGJHDEHCJFA-UHFFFAOYSA-N sulfo hydrogen sulfate;1,4,7,10-tetrazacyclododecane Chemical compound OS(=O)(=O)OS(O)(=O)=O.C1CNCCNCCNCCN1 VIOLGJHDEHCJFA-UHFFFAOYSA-N 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- ILJSQTXMGCGYMG-UHFFFAOYSA-N triacetic acid Chemical class CC(=O)CC(=O)CC(O)=O ILJSQTXMGCGYMG-UHFFFAOYSA-N 0.000 description 1
- HRJSZZAKOGKNGM-UHFFFAOYSA-K trisodium 2-[4,10-bis(carboxylatomethyl)-7-formyl-1,4,7,10-tetrazacyclododec-1-yl]acetate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CN1CCN(CC([O-])=O)CCN(CCN(CC([O-])=O)CC1)C=O HRJSZZAKOGKNGM-UHFFFAOYSA-K 0.000 description 1
- OKHVSTSMWHWVMK-UHFFFAOYSA-K trisodium;2-[4,7-bis(carboxylatomethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CN1CCNCCN(CC([O-])=O)CCN(CC([O-])=O)CC1 OKHVSTSMWHWVMK-UHFFFAOYSA-K 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT97MI001371A IT1292128B1 (it) | 1997-06-11 | 1997-06-11 | Processo per la preparazione di chelanti macrociclici e loro chelati con ioni metallici paramagnetici |
| PCT/EP1998/003308 WO1998056775A1 (en) | 1997-06-11 | 1998-06-03 | A process for the preparation of macrocyclic chelants and the chelates thereof with paramagnetic metal ions |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO996077D0 NO996077D0 (no) | 1999-12-09 |
| NO996077L NO996077L (no) | 2000-02-10 |
| NO313140B1 true NO313140B1 (no) | 2002-08-19 |
Family
ID=11377336
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO19996077A NO313140B1 (no) | 1997-06-11 | 1999-12-09 | Fremgangsmåte ved fremstilling av makrosykliske chelatdannere og chelater derav med paramagnetiske metallioner |
Country Status (15)
| Country | Link |
|---|---|
| US (3) | US5925752A (da) |
| EP (1) | EP0988294B1 (da) |
| JP (1) | JP4351299B2 (da) |
| CN (1) | CN1166649C (da) |
| AT (1) | ATE308528T1 (da) |
| AU (1) | AU8110098A (da) |
| DE (1) | DE69832170T2 (da) |
| DK (1) | DK0988294T3 (da) |
| ES (1) | ES2252845T3 (da) |
| IL (1) | IL133394A (da) |
| IN (1) | IN185469B (da) |
| IT (1) | IT1292128B1 (da) |
| NO (1) | NO313140B1 (da) |
| WO (1) | WO1998056775A1 (da) |
| ZA (1) | ZA985025B (da) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA981883B (en) * | 1997-03-07 | 1998-09-01 | Univ Kansas | Catalysts and methods for catalytic oxidation |
| DE69830160T2 (de) * | 1997-03-07 | 2006-01-19 | The Procter & Gamble Company, Cincinnati | Bleichmittelzusammensetzungen |
| US20080125344A1 (en) * | 2006-11-28 | 2008-05-29 | Daryle Hadley Busch | Bleach compositions |
| US20030017941A1 (en) * | 1997-03-07 | 2003-01-23 | The Procter & Gamble Company | Catalysts and methods for catalytic oxidation |
| IT1292130B1 (it) * | 1997-06-11 | 1999-01-25 | Bracco Spa | Processo per la preparazione dell'acido 1,4,7,10-tetraazaciclododecan -1,4,7-triacetico e suoi derivati |
| IT1292128B1 (it) * | 1997-06-11 | 1999-01-25 | Bracco Spa | Processo per la preparazione di chelanti macrociclici e loro chelati con ioni metallici paramagnetici |
| US6166201A (en) * | 1999-06-25 | 2000-12-26 | Dibra S.P.A. | Process for the preparation of 1,4,7,10-tetraaza-cyclododecane-1,4,7-triacetic acid and the derivatives thereof |
| US20050192195A1 (en) * | 2002-08-27 | 2005-09-01 | Busch Daryle H. | Catalysts and methods for catalytic oxidation |
| US20040048763A1 (en) * | 2002-08-27 | 2004-03-11 | The Procter & Gamble Co. | Bleach compositions |
| DE102009057274B4 (de) | 2009-12-02 | 2011-09-01 | Bayer Schering Pharma Aktiengesellschaft | Gadobutrolherstellung mittels Trioxobicyclo-octan |
| DE102009053252B3 (de) * | 2009-11-09 | 2011-09-01 | Bayer Schering Pharma Aktiengesellschaft | Gadobutrolherstellung mittels keramischer Membran |
| WO2011054480A1 (de) | 2009-11-09 | 2011-05-12 | Bayer Schering Pharma Aktiengesellschaft | Gadobutrolherstellung mittels keramischer membran |
| DE102010013833A1 (de) | 2010-03-29 | 2011-09-29 | Bayer Schering Pharma Aktiengesellschaft | Herstellung von Gadobutrol mittels Dimethylformamiddimethylacetal |
| CN102399199B (zh) * | 2010-09-19 | 2014-01-08 | 广州康臣药物研究有限公司 | 一种磁共振成像造影剂的制备方法 |
| KR20190079682A (ko) * | 2011-04-21 | 2019-07-05 | 바이엘 인텔렉쳐 프로퍼티 게엠베하 | 고순도 가도부트롤의 제조 |
| US10195295B2 (en) | 2014-02-06 | 2019-02-05 | T2Pharma Gmbh | Process for purifying 1,4,7,10-tetra-azacyclododecane-1,4,7,10-tetraacetic acid |
| GB201421162D0 (en) | 2014-11-28 | 2015-01-14 | Ge Healthcare As | Lanthanide complex formulations |
| US10781188B2 (en) | 2015-12-10 | 2020-09-22 | Bracco Imaging S.P.A. | Contrast agents |
| BR112018010815B1 (pt) | 2015-12-10 | 2022-05-17 | Bracco Imaging Spa | Compostos diméricos, complexo quelante e composição farmacêutica compreendendo o refrido complexo quelante |
| HUE056114T2 (hu) | 2016-12-12 | 2022-01-28 | Bracco Imaging Spa | Dimer kontrasztanyagok |
| CN109293592A (zh) * | 2017-07-24 | 2019-02-01 | 天津科伦药物研究有限公司 | 一种制备钆布醇的方法 |
| KR101971435B1 (ko) * | 2017-08-29 | 2019-04-24 | 주식회사 엔지켐생명과학 | 가도부트롤 중간체 및 이를 이용한 가도부트롤의 제조 방법 |
| CN108047151B (zh) * | 2018-01-03 | 2020-08-04 | 广州康瑞泰药业有限公司 | 一种高收率钆布醇的制备方法 |
| WO2020012372A1 (en) * | 2018-07-10 | 2020-01-16 | Biophore India Pharmaceuticals Pvt. Ltd | Process for the preparation of 2,2',2''-(10-((2r,3s)-1,3,4-trihydroxy butan-2-yl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl) triacetic acid and its complexes |
| WO2020084504A1 (en) * | 2018-10-24 | 2020-04-30 | Biophore India Pharmaceuticals Pvt. Ltd | Novel process for the preparation of macrocyclic chelant 2,2',2''-(10-(2-hydroxypropyl)-1,4,7,10-tetra azacyclododecane-1,4,7-triyl) triacetic acid and it's complexes with paramagnetic metal ions |
| US20200397924A1 (en) | 2019-01-28 | 2020-12-24 | Hubei Tianshu Pharmaceutical Co., Ltd | Preparation method of intermediate of gadolinium-based ionic contrast agent and use thereof |
| CN110776649B (zh) * | 2019-11-11 | 2021-10-26 | 重庆师范大学 | 含蒽基的镉-有机超分子聚合物及其制备方法与应用 |
| CN111039885B (zh) * | 2019-12-06 | 2021-03-05 | 广州康瑞泰药业有限公司 | 一种制备高纯度考布曲钙的方法 |
| MX2022007108A (es) | 2019-12-13 | 2022-07-11 | Bracco Imaging Spa | Fabricacion de do3a protegido. |
| EP4255894A1 (en) | 2020-12-04 | 2023-10-11 | Bracco Imaging SPA | Manufacturing process for preparing gadoteridol |
| CN113527223B (zh) * | 2021-06-22 | 2023-05-09 | 安徽普利药业有限公司 | 一种钆布醇的精制方法 |
| CN114085192B (zh) * | 2021-12-30 | 2023-09-19 | 海南普利制药股份有限公司 | 一种钆特醇中间体的精制方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4085106A (en) * | 1976-01-07 | 1978-04-18 | E. I. Du Pont De Nemours And Company | Bicyclic and tricyclic trisaminomethanes |
| US4885363A (en) * | 1987-04-24 | 1989-12-05 | E. R. Squibb & Sons, Inc. | 1-substituted-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs |
| DE4035760A1 (de) * | 1990-11-08 | 1992-05-14 | Schering Ag | Mono-n-substituierte 1,4,7,10-tetraazacyclododecan-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel |
| US5447635A (en) * | 1991-02-26 | 1995-09-05 | Bracco International B.V. | Process of concentration and purification of organic compounds |
| DE4237943C2 (de) * | 1992-11-06 | 1997-10-23 | Schering Ag | Verfahren zur Herstellung von Metallkomplexen der N-beta-Hydroxyalkyl-tri-N-carboxyalkyl-1,4,7,10-tetraazacyclododecan- und N-beta-Hydroxyalkyl-tri-N-carboxyalkyl-1,4,8,11-tetraazacyclotetradecan-Derivate |
| DE4218744C2 (de) * | 1992-06-04 | 1997-11-06 | Schering Ag | Verfahren zur Herstellung von N-ß-Hxdroxyalkyl-tri-N-carboxylalkyl-1,4,7,10-tetraazacyclododecan- und N-ß-Hydroxyalkyl-tri-N-carboxyalkyl-1,4,8,11-tetraazacyclotetradecan-Derivaten und deren Metallkomplexe |
| DE4318369C1 (de) * | 1993-05-28 | 1995-02-09 | Schering Ag | Verwendung von makrocyclischen Metallkomplexen als Temperatursonden |
| IT1292128B1 (it) * | 1997-06-11 | 1999-01-25 | Bracco Spa | Processo per la preparazione di chelanti macrociclici e loro chelati con ioni metallici paramagnetici |
-
1997
- 1997-06-11 IT IT97MI001371A patent/IT1292128B1/it active IP Right Grant
-
1998
- 1998-06-03 DK DK98930787T patent/DK0988294T3/da active
- 1998-06-03 AU AU81100/98A patent/AU8110098A/en not_active Abandoned
- 1998-06-03 AT AT98930787T patent/ATE308528T1/de active
- 1998-06-03 EP EP98930787A patent/EP0988294B1/en not_active Expired - Lifetime
- 1998-06-03 IL IL13339498A patent/IL133394A/en not_active IP Right Cessation
- 1998-06-03 CN CNB988060035A patent/CN1166649C/zh not_active Expired - Lifetime
- 1998-06-03 ES ES98930787T patent/ES2252845T3/es not_active Expired - Lifetime
- 1998-06-03 DE DE69832170T patent/DE69832170T2/de not_active Expired - Lifetime
- 1998-06-03 WO PCT/EP1998/003308 patent/WO1998056775A1/en active IP Right Grant
- 1998-06-03 JP JP50149799A patent/JP4351299B2/ja not_active Expired - Lifetime
- 1998-06-10 IN IN1251MA1998 patent/IN185469B/en unknown
- 1998-06-10 ZA ZA985025A patent/ZA985025B/xx unknown
- 1998-06-10 US US09/095,015 patent/US5925752A/en not_active Expired - Lifetime
-
1999
- 1999-05-24 US US09/317,272 patent/US6046324A/en not_active Expired - Lifetime
- 1999-05-24 US US09/317,271 patent/US6042810A/en not_active Expired - Lifetime
- 1999-12-09 NO NO19996077A patent/NO313140B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0988294B1 (en) | 2005-11-02 |
| JP2002510296A (ja) | 2002-04-02 |
| IL133394A (en) | 2004-02-08 |
| EP0988294A1 (en) | 2000-03-29 |
| NO996077L (no) | 2000-02-10 |
| IL133394A0 (en) | 2001-04-30 |
| US6046324A (en) | 2000-04-04 |
| US6042810A (en) | 2000-03-28 |
| DK0988294T3 (da) | 2006-02-13 |
| DE69832170T2 (de) | 2006-07-13 |
| WO1998056775A1 (en) | 1998-12-17 |
| CN1166649C (zh) | 2004-09-15 |
| ATE308528T1 (de) | 2005-11-15 |
| ES2252845T3 (es) | 2006-05-16 |
| AU8110098A (en) | 1998-12-30 |
| IN185469B (da) | 2001-01-27 |
| DE69832170D1 (de) | 2005-12-08 |
| JP4351299B2 (ja) | 2009-10-28 |
| ITMI971371A1 (it) | 1998-12-11 |
| IT1292128B1 (it) | 1999-01-25 |
| ZA985025B (en) | 1999-01-25 |
| NO996077D0 (no) | 1999-12-09 |
| ITMI971371A0 (da) | 1997-06-11 |
| CN1259939A (zh) | 2000-07-12 |
| US5925752A (en) | 1999-07-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO313140B1 (no) | Fremgangsmåte ved fremstilling av makrosykliske chelatdannere og chelater derav med paramagnetiske metallioner | |
| JP5204724B2 (ja) | １，４，７，１０−テトラアザシクロドデカン−１，４，７−三酢酸及びその誘導体の調製のための方法 | |
| KR100269081B1 (ko) | N-베타-히드록시알킬-트리-n-카르복시알킬-1,4,7,10-테트라아자시클로도데칸및n-베타-히드록시알킬-트리-n-카르복시알킬-1,4,8,11-테트라아자시클로테트라데칸유도체및그들의금속착화합물의제조방법 | |
| CA2777314C (en) | Process for the preparation of calcobutrol | |
| WO2019143074A1 (ko) | 칼코부트롤의 제조방법 | |
| CA3074161C (en) | Gadobutrol intermediate and gadobutrol production method using same | |
| CN111375071B (zh) | 一种制备造影剂方法 | |
| EP3875453A1 (en) | Method for manufacturing calcobutrol | |
| EP0484122B1 (en) | Method for obtaining high-purity cinnamic acid | |
| EP0988305B1 (en) | A PROCESS FOR THE PREPARATION OF 5H,9bH-2a, 4a,7,9a-OCTAHYDROTETRAAZACYCLOOCTA [cd] PENTALENE | |
| CN103221369A (zh) | 金刚烷多元醇的制造方法 | |
| CN117412980A (zh) | 二聚体造影剂的制备 | |
| SU895287A3 (ru) | Способ получени N,N-ди-(с @ -с @ )-алкил-4,4 @ -бипиридиловой соли | |
| CN114853690A (zh) | 一种布醇的制备方法 | |
| CN117440959A (zh) | 用于制造钆络合物溶液的方法 | |
| CN101712682A (zh) | 他索沙坦的合成方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK1K | Patent expired |